Discovery reveals how obesity causes disease—and two ways to stop it

July 23, 2018, University of Virginia
Norbert Leitinger, Ph.D., of the University of Virginia School of Medicine, led a team that determined why obesity causes harmful inflammation that can lead to diabetes, clogged arteries and other health problems. Doctors may be able to use this knowledge to battle these chronic diseases and others driven by damaging inflammation. Credit: Dan Addison, University of Virginia Communications

New research from the University of Virginia School of Medicine explains why obesity causes harmful inflammation that can lead to diabetes, clogged arteries and other health problems. Doctors may be able to use this knowledge to battle these chronic diseases and others driven by damaging inflammation.

"All these diseases have a common denominator," said researcher Vlad Serbulea, Ph.D. "It may well be that we've identified what starts off the whole cascade of inflammation and metabolic changes."

Effects of Obesity

The researchers, for the first time, were able to explain why resident immune in fat tissue—immune cells that are thought to be beneficial—turn harmful during , causing unwanted and unhealthy inflammation.

The research team, led by Norbert Leitinger, Ph.D., of UVA's Department of Pharmacology, found that damaging "" produced within our bodies react with substances known as lipids inside fat tissue. This attack on the lipids prompts them to cause inflammation, a natural immune response.

"Free radicals are so reactive that they want to hitch onto something," Serbulea explained. "Lipids happen to be a very good sink for these radicals to combine with."

That results in a process called " oxidation." At first the scientists expected the oxidized lipids would prove harmful, but it wasn't that simple. Some of the oxidized lipids were causing damaging inflammation—reprogramming immune cells to become hyperactive—but other oxidized lipids were present in healthy tissue. Specifically, shorter "truncated" ones are protective, while longer "full-length" ones were inflammatory.

"When we compare healthy and obese tissue, what seems to change is the ratio of full-length and truncated oxidized lipids," Serbulea said. "Our studies show that the full-length, or longer, oxidized lipids are quite inflammatory. They promote inflammation within these immune cells, and we think that instigates and perpetuates the disease process within [fat] tissue during obesity."

A Drug to Combat the Inflammation of Obesity

Now that scientists know which oxidized lipids are causing problems, and how, they can seek to block them to prevent . They may be able to develop a drug, for example, that would reduce the number of harmful, full-length oxidized lipids.

"Now, knowing that some of these molecules are really bad guys, so to speak, eliminating them from the circulation may have a very beneficial effect on ," said Leitinger, of UVA's Robert M. Berne Cardiovascular Research Center and UVA's Carter Immunology Center.

Alternately, doctors might want to promote the number of beneficial, shorter phospholipids. "Inflammation is important for your body's defenses, so you don't want to eliminate it completely," Leitinger said. "It's a question of finding the right balance."

By restoring that balance, doctors may be able to make significant inroads against chronic diseases that now plague millions of people.

"One thing we showed is that metabolism in the is an exploitable target," Serbulea said. "It's been a target in diseases like cancer, but now for obesity and atherosclerosis it becomes more and more of a focus."

Explore further: Computational models provide novel genetic insights into atherosclerosis

More information: Vlad Serbulea et al, Macrophage phenotype and bioenergetics are controlled by oxidized phospholipids identified in lean and obese adipose tissue, Proceedings of the National Academy of Sciences (2018). DOI: 10.1073/pnas.1800544115

Related Stories

Computational models provide novel genetic insights into atherosclerosis

June 28, 2018
Researchers have identified a new gene-activation pathway caused by lipids associated with coronary artery disease, a finding that could help identify new directions in research and drug development. The study was published ...

Natural lipid acts as potent anti-inflammatory

July 6, 2018
National Institutes of Health researchers have identified a naturally occurring lipid—a waxy, fatty acid—used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, ...

Study probes the role of key protein linked to heart disease, diabetes

March 23, 2018
Diet-induced diabetes, obesity, and heart disease are leading causes of death worldwide. In their search for novel therapies for these related chronic illnesses, Yale researchers investigated a protein called ANGPTL4. The ...

Accelerated immune aging may contribute to obesity-linked metabolic disease

November 7, 2016
Obese individuals are at an elevated risk of developing comorbid cardiovascular and metabolic diseases, such as type 2 diabetes. Some research suggests that these comorbid diseases develop in response to chronic inflammation ...

Protein in 'good cholesterol' may be a key to treating pulmonary hypertension

August 27, 2014
Oxidized lipids are known to play a key role in inflaming blood vessels and hardening arteries, which causes diseases like atherosclerosis. A new study at UCLA demonstrates that they may also contribute to pulmonary hypertension, ...

Researchers discover new source of skin defects in eczema

February 27, 2018
Researchers at National Jewish Health have discovered a cause of the dry, inflamed and itchy skin that plagues eczema patients. A team led by Donald Leung, MD, Ph.D., has shown that an immune system skewed toward allergy ...

Recommended for you

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.